Forefront Analytics LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 7.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 787 shares of the healthcare conglomerate’s stock after acquiring an additional 54 shares during the period. Forefront Analytics LLC’s holdings in UnitedHealth Group were worth $400,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also added to or reduced their stakes in the company. NewSquare Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group during the fourth quarter valued at $26,000. Hurley Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth about $30,000. Finally, AlphaMark Advisors LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $30,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.
Analyst Ratings Changes
UNH has been the subject of several recent research reports. KeyCorp cut their target price on shares of UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating for the company in a report on Monday, April 21st. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Oppenheimer lowered their price target on UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating on the stock in a research report on Monday, April 21st. JPMorgan Chase & Co. reduced their target price on UnitedHealth Group from $652.00 to $525.00 and set an “overweight” rating for the company in a research note on Thursday, April 24th. Finally, Mizuho upped their price objective on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 9th. Four equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $596.86.
UnitedHealth Group Trading Down 1.3 %
NYSE UNH opened at $380.72 on Friday. The firm has a market cap of $346.54 billion, a price-to-earnings ratio of 24.56, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a one year low of $378.54 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a 50 day simple moving average of $488.01 and a 200-day simple moving average of $522.60.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.21%. UnitedHealth Group’s dividend payout ratio is currently 35.18%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Google Is Betting Big on Nuclear Reactors—Should You?
- How Can Investors Benefit From After-Hours Trading
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.